Related references
Note: Only part of the references are listed.Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment
Hao Cai et al.
ACTA PHARMACEUTICA SINICA B (2021)
Engineered liposomes bearing camptothecin analogue for tumour targeting:in vitroandex-vivostudies
Shivani Saraf et al.
JOURNAL OF LIPOSOME RESEARCH (2021)
pH sensitive liposomes assisted specific and improved breast cancer therapy using co-delivery of SIRT1 shRNA and Docetaxel
Rajan Swami et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)
Cold atmospheric plasma modification of curcumin loaded in tri-phosphate chitosan nanoparticles enhanced breast cancer cells apoptosis
Azadeh Sadoughi et al.
POLYMERS FOR ADVANCED TECHNOLOGIES (2021)
Lactoferrin-dual drug nanoconjugate: Synergistic anti-tumor efficacy of docetaxel and the NF-κB inhibitor celastrol
Mona A. Abdelmoneem et al.
MATERIALS SCIENCE AND ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2021)
Nanocomposite scaffolds for accelerating chronic wound healing by enhancing angiogenesis
Hamed Nosrati et al.
JOURNAL OF NANOBIOTECHNOLOGY (2021)
Chondroitin sulfate-based nanoparticles for enhanced chemo-photodynamic therapy overcoming multidrug resistance and lung metastasis of breast cancer
Xiaoqun Shi et al.
CARBOHYDRATE POLYMERS (2021)
Tumor microenvironment-responsive PEGylated heparin-pyropheophorbide-a nanoconjugates for photodynamic therapy`
Yahui Wu et al.
CARBOHYDRATE POLYMERS (2021)
A novel 'smart' PNIPAM-based copolymer for breast cancer targeted therapy: Synthesis, and characterization of dual pH/temperature-responsive lactoferrin-targeted PNIPAM-co-AA
Osama R. M. Metawea et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2021)
Novel dendritic polyglycerol-conjugated, mesoporous silica-based targeting nanocarriers for co-delivery of doxorubicin and tariquidar to overcome multidrug resistance in breast cancer stem cells
Yuanwei Pan et al.
JOURNAL OF CONTROLLED RELEASE (2021)
Preface
Renato Dalpozzo
MINI-REVIEWS IN ORGANIC CHEMISTRY (2021)
Polysaccharide-based nanomedicines for cancer immunotherapy: A review
Yujun Zeng et al.
BIOACTIVE MATERIALS (2021)
PEGylated N-(2 hydroxypropyl) methacrylamide polymeric micelles as nanocarriers for the delivery of doxorubicin in breast cancer
Yamini Bobde et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2021)
Nanomedicines modulating myeloid-derived suppressor cells for improving cancer immunotherapy
Xinghang Dai et al.
NANO TODAY (2021)
Glucosylated Polymeric Micelles Actively Target a Breast Cancer Model
Nicole Lecot et al.
ADVANCED THERAPEUTICS (2021)
Suppressing Sart1 to modulate macrophage polarization by siRNA-loaded liposomes: a promising therapeutic strategy for pulmonary fibrosis
Ting Pan et al.
THERANOSTICS (2021)
Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer
Min Fu et al.
JOURNAL OF DRUG TARGETING (2020)
CDK4/6 inhibitors in breast cancer - from in vitro models to clinical trials
Lubaid Saleh et al.
ACTA ONCOLOGICA (2020)
Stimuli-responsive Drug Delivery Nanocarriers in the Treatment of Breast Cancer
Joao A. Oshiro-Junior et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy
Jianping Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Exosome-mediated siRNA delivery to suppress postoperative breast cancer metastasis
Liuwan Zhao et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Dual-targeting liposome modified by glutamic hexapeptide and folic acid for bone metastatic breast cancer
Yang Yang et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2020)
Synthesis of lactoferrin mesoporous silica nanoparticles for pemetrexed/ellagic acid synergistic breast cancer therapy
Omnia M. Ali et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
Advances in liposomal drug delivery to cancer: An overview
Shivani Saraf et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2020)
Systemic Delivery of Aptamer-Conjugated XBP1 siRNA Nanoparticles for Efficient Suppression of HER2+Breast Cancer
Long Zhang et al.
ACS APPLIED MATERIALS & INTERFACES (2020)
Co-Administration of Tretinoin Enhances the Anti-Cancer Efficacy of Etoposide via Tumor-Targeted Green Nano-Micelles
Mohamed Gaber et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2020)
Biologicals to direct nanotherapeutics towards HER2-positive breast cancers
Gautam Kumar et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2020)
Combination of magnetic targeting with synergistic inhibition of NF-κB and glutathione via micellar drug nanomedicine enhances its anti-tumor efficacy
Kholod A. Elhasany et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2020)
Emerging nanomedicines for effective breast cancer immunotherapy
Amirhossein Bahreyni et al.
JOURNAL OF NANOBIOTECHNOLOGY (2020)
Combination Cancer Therapy Using Multifunctional Liposomes
Ankit Jain et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2020)
DOX-loaded peptide dendritic copolymer nanoparticles for combating multidrug resistance by regulating the lysosomal pathway of apoptosis in breast cancer cells
Jianxi Wang et al.
JOURNAL OF MATERIALS CHEMISTRY B (2020)
Modulating T-cell-based cancer immunotherapy via particulate systems
Duy Hieu Truong et al.
JOURNAL OF DRUG TARGETING (2019)
Temperature-sensitive liposomes for co-delivery of tamoxifen and imatinib for synergistic breast cancer treatment
Anup Jose et al.
JOURNAL OF LIPOSOME RESEARCH (2019)
The viral approach to breast cancer immunotherapy
Atefeh Arab et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Dual-functionalized liposome by co-delivery of paclitaxel with sorafenib for synergistic antitumor efficacy and reversion of multidrug resistance
Meng Lei et al.
DRUG DELIVERY (2019)
Hyaluronic acid conjugated multi-walled carbon nanotubes for colon cancer targeting
Shiv Kumar Prajapati et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
Specific drug delivery efficiently induced human breast tumor regression using a lipoplex by non-covalent association with anti-tumor antibodies
Yu-Ling Lin et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
Liposomes modified with double-branched biotin: A novel and effective way to promote breast cancer targeting
Runxin Lu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Milk exosomes - Natural nanoparticles for siRNA delivery
Farrukh Aqil et al.
CANCER LETTERS (2019)
Development of liposomes using formulation by design: Basics to recent advances
Ankit Jain et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2019)
Co-Delivery of Paclitaxel and PLK1-Targeted siRNA Using Aptamer-Functionalized Cationic Liposome for Synergistic Anti-Breast Cancer Effects In Vivo
Sheng Yu et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2019)
Methotrexate anticancer drug delivery to breast cancer cell lines by iron oxide magnetic based nanocarrier
Elahe Attari et al.
JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A (2019)
Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells
Na Li et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
Paclitaxel-Loaded Folate-Coated pH-Sensitive Liposomes Enhance Cellular Uptake and Antitumor Activity
Liziane O. F. Monteiro et al.
MOLECULAR PHARMACEUTICS (2019)
Ultrastructural Changes and Antitumor Effects of Doxorubicin/ Thymoquinone-Loaded CaCO3 Nanoparticles on Breast Cancer Cell Line
Kehinde Muibat Ibiyeye et al.
FRONTIERS IN ONCOLOGY (2019)
Improving breast cancer therapy using doxorubicin loaded solid lipid nanoparticles: Synthesis of a novel arginine-glycine-aspartic tripeptide conjugated, pH sensitive lipid and evaluation of the nanomedicine in vitro and in vivo
Gang Zheng et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer
Xin Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Rationally designed hyaluronic acid-based nano-complexes for pentamidine delivery
Flavia Carton et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Engineered polymeric iron oxide nanoparticles as potential drug carrier for targeted delivery of docetaxel to breast cancer cells
Jnanranjan Panda et al.
JOURNAL OF MAGNETISM AND MAGNETIC MATERIALS (2019)
Novel Strategies for Targeting Prostate Cancer
Pritish Kumar Panda et al.
CURRENT DRUG DELIVERY (2019)
Breast cancer
Nadia Harbeck et al.
NATURE REVIEWS DISEASE PRIMERS (2019)
Hyaluronic acid modified liposomes for targeted delivery of doxorubicin and paclitaxel to CD44 overexpressing tumor cells with improved dual-drugs synergistic effect
Meijia Song et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2019)
Ultrasmall nanostructured drug based pH-sensitive liposome for effective treatment of drug-resistant tumor
Yanyan Li et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
Sequentially self-assembled polysaccharide-based nanocomplexes for combined chemotherapy and photodynamic therapy of breast cancer
Yaping Wang et al.
CARBOHYDRATE POLYMERS (2019)
In the triple-negative breast cancer MDA-MB-231 cell line, sulforaphane enhances the intracellular accumulation and anticancer action of doxorubicin encapsulated in liposomes
Lidia Mielczarek et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Rational combination immunotherapeutic approaches for effective cancer treatment
Cao Dai Phung et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
G. von Minckwitz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Combining hydrophilic chemotherapy and hydrophobic phytotherapy via tumor-targeted albumin-QDs nano-hybrids: covalent coupling and phospholipid complexation approaches
Dina G. Zayed et al.
JOURNAL OF NANOBIOTECHNOLOGY (2019)
Co-delivery of Cyclopamine and Doxorubicin Mediated by Bovine Serum Albumin Nanoparticles Reverses Doxorubicin Resistance in Breast Cancer by Down-regulating P-glycoprotein Expression
Yong-lin Lu et al.
JOURNAL OF CANCER (2019)
Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel
Fadwa Odeh et al.
HELIYON (2019)
Combination Immunotherapy Strategies in Breast Cancer
Brie M. Chun et al.
CURRENT BREAST CANCER REPORTS (2019)
Docetaxel-loaded nanostructured lipid carriers functionalized with trastuzumab (Herceptin) for HER2-positive breast cancer cells
Jaleh Varshosaz et al.
JOURNAL OF LIPOSOME RESEARCH (2018)
Ultrasound-based triggered drug delivery to tumors
Ankit Jain et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2018)
Chemotherapy Sensitizes Therapy-Resistant Cells to Mild Hyperthermia by Suppressing Heat Shock Protein 27 Expression in Triple-Negative Breast Cancer
Chaofeng Mu et al.
CLINICAL CANCER RESEARCH (2018)
Nanocarrier Based Advances in Drug Delivery to Tumor: An Overview
Ankit Jain et al.
CURRENT DRUG TARGETS (2018)
Advances in Tumor Targeted Liposomes
A. Jain et al.
CURRENT MOLECULAR MEDICINE (2018)
Development of redox-responsive theranostic nanoparticles for near-infrared fluorescence imaging-guided photodynamic/chemotherapy of tumor
Xiaoye Yang et al.
DRUG DELIVERY (2018)
Nanoparticles for dendritic cell-based immunotherapy
Tuan Hiep Tran et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2018)
Phytosomal bilayer-enveloped casein micelles for codelivery of monascus yellow pigments and resveratrol to breast cancer
Shaymaa W. El-Far et al.
NANOMEDICINE (2018)
Folate conjugated vs PEGylated phytosomal casein nanocarriers for codelivery of fungal- and herbal-derived anticancer drugs
Shaymaa W. El-Far et al.
NANOMEDICINE (2018)
Toxicological study of a new doxorubicin-loaded pH-sensitive liposome: A preclinical approach
Juliana de Oliveira Silva et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2018)
Lactobionic/Folate Dual-Targeted Amphiphilic Maltodextrin-Based Micelles for Targeted Codelivery of Sulfasalazine and Resveratrol to Hepatocellular Carcinoma
Doaa M. Anwar et al.
BIOCONJUGATE CHEMISTRY (2018)
Nanocarrier-Based Combination Chemotherapy for Resistant Tumor: Development, Characterization, and Ex Vivo Cytotoxicity Assessment
Sarjana Raikwar et al.
AAPS PHARMSCITECH (2018)
Lactoferrin-tagged quantum dots-based theranostic nanocapsules for combined COX-2 inhibitor/herbal therapy of breast cancer
Ahmed S. AbdElhamid et al.
NANOMEDICINE (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Immunoliposomes with Simvastatin as a Potential Therapeutic in Treatment of Breast Cancer Cells Overexpressing HER2-An In Vitro Study
Lucyna Matusewicz et al.
CANCERS (2018)
European Breast Cancer Conference manifesto on breast centres/units
Fatima Cardoso et al.
EUROPEAN JOURNAL OF CANCER (2017)
CXCR4 targeted dendrimer for anti-cancer drug delivery and breast cancer cell migration inhibition
Chuda Chittasupho et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis
Xinyan Chen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
A Liposome Encapsulated Ruthenium Polypyridine Complex as a Theranostic Platform for Triple-Negative Breast Cancer
Jianliang Shen et al.
NANO LETTERS (2017)
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
Sushrut Kamerkar et al.
NATURE (2017)
In vivo study of doxorubicin-loaded cell-penetrating peptide-modified pH-sensitive liposomes: biocompatibility, bio-distribution, and pharmacodynamics in BALB/c nude mice bearing human breast tumors
Yuan Ding et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Combination of using prodrug-modified cationic liposome nanocomplexes and a potentiating strategy via targeted co-delivery of gemcitabine and docetaxel for CD44-overexpressed triple negative breast cancer therapy
Yang Fan et al.
ACTA BIOMATERIALIA (2017)
Pre-metastatic niches: organ-specific homes for metastases
Hector Peinado et al.
NATURE REVIEWS CANCER (2017)
Multipronged, strategic delivery of paclitaxel-topotecan using engineered liposomes to ovarian cancer
Ankit Jain et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2016)
In vitro release kinetics model fitting of liposomes: An insight
Ankit Jain et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2016)
Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy
Josimar O. Eloy et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Topotecan Liposomes: A Visit from a Molecular to a Therapeutic Platform
Shivani Saraf et al.
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS (2016)
Nanoparticles with Optimal Ratiometric Co-Delivery of Docetaxel with Gambogic Acid for Treatment of Multidrug-Resistant Breast Cancer
Youwei Xu et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2016)
An in-vivo study for targeted delivery of copper-organic complex to breast cancer using chitosan polymer nanoparticles
Arindam Pramanik et al.
MATERIALS SCIENCE & ENGINEERING C-MATERIALS FOR BIOLOGICAL APPLICATIONS (2016)
CDK4/6 Inhibitors : Promising Opportunities beyond Breast Cancer
Joline S. J. Lim et al.
CANCER DISCOVERY (2016)
Phage display as a promising approach for vaccine development
Leili Aghebati-Maleki et al.
JOURNAL OF BIOMEDICAL SCIENCE (2016)
Human epidermal growth factor receptor-2 antibodies enhance the specificity and anticancer activity of light-sensitive doxorubicin-labeled liposomes
Qingpo Li et al.
BIOMATERIALS (2015)
Albumin-bound nanoparticle (nab) paclitaxel exhibits enhanced paclitaxel tissue distribution and tumor penetration
Nianhang Chen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2015)
Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor
James N. Kochenderfer et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
Naiyer A. Rizvi et al.
LANCET ONCOLOGY (2015)
Anti-HER2/neu peptide-conjugated iron oxide nanoparticles for targeted delivery of paclitaxel to breast cancer cells
Qingxin Mu et al.
NANOSCALE (2015)
Selective resistance to the PARP inhibitor olaparib in a mouse model for BRCA1-deficient metaplastic breast cancer
Linda Henneman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
T-cell-based Immunotherapy: Adoptive Cell Transfer and Checkpoint Inhibition
Roch Houot et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Docetaxel Alone or in Combination With a Therapeutic Cancer Vaccine (PANVAC) in Patients With Metastatic Breast Cancer A Randomized Clinical Trial
Christopher R. Heery et al.
JAMA ONCOLOGY (2015)
Role of the Breast Cancer Resistance Protein (BCRP/ABCG2) in Drug Transport-an Update
Qingcheng Mao et al.
AAPS JOURNAL (2015)
BRCA2-Deficient Sarcomatoid Mammary Tumors Exhibit Multidrug Resistance
Janneke E. Jaspers et al.
CANCER RESEARCH (2015)
Immunomodulatory Antibody Therapy of Cancer: The Closer, the Better
Roxana S. Dronca et al.
CLINICAL CANCER RESEARCH (2015)
Adoptive Immunotherapy for Cancer or Viruses
Marcela V. Maus et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
The IL-2 cytokine family in cancer immunotherapy
Geok Choo Sim et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2014)
Various ways to improve whole cancer cell vaccines
Laetitia Cicchelero et al.
EXPERT REVIEW OF VACCINES (2014)
Curcumin-primed exosomes mitigate endothelial cell dysfunction during hyperhomocysteinemia
A. Kalani et al.
LIFE SCIENCES (2014)
pH-sensitive polymeric nanoparticles for tumor-targeting doxorubicin delivery: concept and recent advances
Fenghua Meng et al.
NANOMEDICINE (2014)
Breast Cancer: Current Developments in Molecular Approaches to Diagnosis and Treatment
Jo-Anne la Mare et al.
Recent Patents on Anti-Cancer Drug Discovery (2014)
Classification of current anticancer immunotherapies
Lorenzo Galluzzi et al.
ONCOTARGET (2014)
Immune system targeting by biodegradable nanoparticles for cancer vaccines
Joana M. Silva et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Dual drug delivery using smart liposomes for triggered release of anticancer agents
Ankit Jain et al.
JOURNAL OF NANOPARTICLE RESEARCH (2013)
ADOPTIVE CELL THERAPY Honing that killer instinct
Courtney Humphries
NATURE (2013)
Nanoparticle and targeted systems for cancer therapy
Lisa Brannon-Peppas et al.
ADVANCED DRUG DELIVERY REVIEWS (2012)
Dual-functional liposome for tumor targeting and overcoming multidrug resistance in hepatocellular carcinoma cells
Xinxin Zhang et al.
BIOMATERIALS (2012)
Overcoming multidrug resistance by co-delivery of Mdr-1 and survivin-targeting RNA with reduction-responsible cationic poly(β-amino esters)
Qi Yin et al.
BIOMATERIALS (2012)
Genetic cancer vaccines: current status and perspectives
Luigi Aurisicchio et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2012)
Modification of the DNA Damage Response by Therapeutic CDK4/6 Inhibition
Jeffry L. Dean et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Trastuzumab for HER2-Positive Metastatic Breast Cancer: Clinical and Economic Considerations
Alwin Jeyakumar et al.
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
Tumor Metastasis: Molecular Insights and Evolving Paradigms
Scott Valastyan et al.
CELL (2011)
Metastatic Behavior of Breast Cancer Subtypes
Hagen Kennecke et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Exosomes/microvesicles as a mechanism of cell-to-cell communication
Giovanni Camussi et al.
KIDNEY INTERNATIONAL (2010)
Metronomic Chemotherapy Enhances Antitumor Effects of Cancer Vaccine by Depleting Regulatory T Lymphocytes and Inhibiting Tumor Angiogenesis
Chi-An Chen et al.
MOLECULAR THERAPY (2010)
Fighting cancers from within: augmenting tumor immunity with cytokine therapy
Marc Pellegrini et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2010)
Monoclonal antibodies: versatile platforms for cancer immunotherapy
Louis M. Weiner et al.
NATURE REVIEWS IMMUNOLOGY (2010)
ABC transporters in cancer: more than just drug efflux pumps
Jamie I. Fletcher et al.
NATURE REVIEWS CANCER (2010)
T Helper 17 Cells Promote Cytotoxic T Cell Activation in Tumor Immunity
Natalia Martin-Orozco et al.
IMMUNITY (2009)
Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies
Marc Pellegrini et al.
NATURE MEDICINE (2009)
The regulatory function of umbilical cord blood CD4+CD25+ T cells stimulated with anti-CD3/anti-CD28 and exogenous interleukin (IL)-2 or IL-15
Chen-Cheng Lee et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2009)
IL-21 Is Required to Control Chronic Viral Infection
Heidi Elsaesser et al.
SCIENCE (2009)
The metastatic niche: adapting the foreign soil
Bethan Psaila et al.
NATURE REVIEWS CANCER (2009)
Cell cycle, CDKs and cancer: a changing paradigm
Marcos Malumbres et al.
NATURE REVIEWS CANCER (2009)
Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice
Z. J. Ren et al.
VACCINE (2008)
Immunotherapy of established (pre) malignant disease by synthetic long peptide vaccines
Cornelis J. M. Melief et al.
NATURE REVIEWS CANCER (2008)
IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells
Thomas Korn et al.
NATURE (2007)
Immunostimulatory monoclonal antibodies for cancer therapy
Ignacio Melero et al.
NATURE REVIEWS CANCER (2007)
Nanotechnology in cancer therapeutics: bioconjugated nanoparticles for drug delivery
Rajni Sinha et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Cyclins: Roles in mitogenic signaling and oncogenic transformation
EA Musgrove
GROWTH FACTORS (2006)
Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors
KM Laginha et al.
CLINICAL CANCER RESEARCH (2005)
Cancer nanotechnology: Opportunities and challenges
M Ferrari
NATURE REVIEWS CANCER (2005)
Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments
M Gaubin et al.
DNA AND CELL BIOLOGY (2003)
Targeting the prostate for destruction through a vascular address
W Arap et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
